PremiumCompany AnnouncementsHSBC Advances Share Buy-Back with Further UK and Hong Kong Repurchases19h ago
PremiumRatingsGSK: Pipeline Optionality Recognized but Near-Term Data Gaps Keep Rating at Hold and Price Target Unchanged at 2,350 GBp3d agoGSK
GSK: Pipeline Optionality Recognized but Near-Term Data Gaps Keep Rating at Hold and Price Target Unchanged at 2,350 GBp